MedTrace Logo

Medical Education for Better Multiple Sclerosis Outcomes

NCT03134794 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2020-10-19

No results posted yet for this study

Summary

The main objectives of this study are:

i) To design an educational tool to train physicians in overcome cognitive factors associated with therapeutic inertia.

ii) To determine the feasibility and efficacy of an educational tool to overcome therapeutic inertia among neurologists caring for MS patients

iii) identify the best strategy to disseminate an educational program to train physicians taking into account regional and practice variations.

iv) To explore whether multiple sclerosis (MS) patients' risk category influence the incidence of therapeutic inertia in neurologists that may require a segmentation strategy in medical education.

v) To assess how participants handle uncertainty when making treatment decisions by measuring pupil variation from baseline (Canadian study).

vi) To evaluate the effect of the TLS on TI by assessing differences pupil variability between the intervention and control groups (Canadian study).

A multicenter, randomized, study including an educational intervention (applying the traffic light system) to overcome therapeutic inertia in MS care.

Conditions

Interventions

BEHAVIORAL

Educational intervention applying the traffic light system (TLS)

The TLS emerged to facilitate consumers' decisions. It has been applyied in medical decision making.

Sponsors & Collaborators

  • Roche Pharma AG

    collaborator INDUSTRY

  • Unity Health Toronto

    lead OTHER

Principal Investigators

  • Gustavo Saposnik · University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
23 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-22
Primary Completion
2018-10-30
Completion
2018-10-30

Countries

  • Argentina
  • Canada
  • Chile
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03134794 on ClinicalTrials.gov